[Home]   [Full version]  

60 second test could help early diagnosis of common brain diseases

Aug 22 ,Medicine & Health


Until recently physicians have had to rely on time-consuming and uncertain behavioural examinations to diagnose the onset of brain diseases such as multiple sclerosis, Alzheimer's and schizophrenia.

Research published next week in the Institute of Physics' Journal of Neural Engineering suggests that we could soon be able to diagnose the onset of many brain diseases by analysing the tiny magnetic fields produced by neuron activity in the brain.

This is a significant breakthrough for neurologists and psychiatrists as it could present a fast and simple screening test for brain diseases, while also helping differentiate between different brain diseases that have similar symptoms.

A team of investigators from the University of Minnesota Medical School in Minneapolis, US, led by Professor Apostolos P. Georgopoulos, has been analysing the magnetic charges released when neuronal populations in our brains 'couple'. By comparing the patterns of tiny magnetic charges in healthy brains to those afflicted with common diseases such as Alzheimer's, the team has been able to identify the patterns commonly associated with these debilitating diseases.

A process called magnetoencephalography (MEG), a non-invasive measurement of magnetic fields in the brain, has been used to examine a total of 142 volunteers during tests which last between 45-60 seconds. The team first studied 52 volunteers to find patterns of neural activity that could identify all the different illnesses. They then tested a further 46 patients to see whether the patterns found from the first group could accurately diagnose disease within a second group. Here, many of the predictors found from the first set of participants also correctly diagnosed more than 90% of subjects in the second sample.

Professor Georgopoulos said, "We want to continue and acquire data from a large number of subjects - patients and matched controls. The throughput of this MEG test is large so we can continue a high rate of testing and we hope that clinical applications can become a reality in a year or two."

Diagnosing illnesses like Alzheimer's has always been very difficult, particularly in the early stages. Physicians are forced to rely on conversations with patients, memory tests, physical examinations and, occasionally, brain scans. It is sometimes not until post-mortem or after a biopsy that cause of illness can be confirmed.

Source: Institute of Physics

Related stories:

Computers make sense of experiments on human disease
Increased use of computers to create predictive models of human disease is likely following a workshop organised by the European Science Foundation (ESF), which urged for a collaborative effort between specialists in the field. Human disease research produces an enormous amount of data from different sources such as animal models, high throughput genetic screening of human tissue, and in vitro laboratory experiments. This data operates at different levels and scales including genes, molecules, cells, tissues and whole organs, embodying a huge amount of potentially valuable insight that current computer modelling approaches often fail to exploit properly.
New candidate genes for schizophrenia identified
Schizophrenia is a severe psychiatric disease characterized by disorganized behavior, delusions and hallucinations. Sadly, there is no clear understanding of its cause.
Helping Lost Neurons Find Their Way
Spinal cord injuries are often a worst-case diagnosis for people who suffer accidents because they may mean permanent disability. Unlike a broken leg or pulled muscle, spinal cord injuries do not heal themselves over time.
Scientists trace extensive networks regulating alternative RNA splicing
RNA targets of tissue-specific splicing factors Fox-1 and Fox-2 are successfully predicted
Two professors at Cold Spring Harbor Laboratory (CSHL) have succeeded in tracing intricate biochemical networks involving a class of proteins that enable genes to express themselves in specific tissues at particular moments in development.
Gene enhancer in evolution of human opposable thumb
Scientists have discovered a gene enhancer, known as HACNS1, that may have contributed to the evolution of the uniquely opposable human thumb, and possibly also modifications in the ankle or foot that allow humans to walk on two legs, according to a paper published in Science on Sept. 5, 2008.
New methods identify and manipulate 'newborn' cells in animal model of Parkinson's disease
When cells in the brain are lost through disease or injury, neighboring cells begin to divide and multiply, but only a few areas in the brain are able to produce new neurons. Patients with Parkinson's disease suffer degeneration of certain neurons that reside in an area of the brain called the substantia nigra and project into the striatum. Many of the newborn cells in these areas have not been well described because of limitations of methods used to characterize them.
Drugs to inhibit blood vessel growth show promise in rat model of deadly brain tumor
In a landmark study, Medical College of Wisconsin researchers in Milwaukee report that drugs used to inhibit a specific fatty acid in rat brains with glioblastoma-like tumors not only reduced new blood vessel growth and tumor size dramatically, but also prolonged survival. The study is the featured cover story of the August, 2008 Journal of Cerebral Blood Flow & Metabolism.


When neurons fire up: Study sheds light on rhythms of the brain
In our brains, groups of neurons fire up simultaneously for just milliseconds at a time, in random rhythms, similar to twinkling lightning bugs in our backyards. New research from neuroscientists at Indiana University and the University of Montreal provides a model -- a rhyme and reason -- for this random synchronization.

News discussion:

Medicine & Health news

[Home]   [Full version]